UBS Group’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.82M Sell
712,252
-531,224
-43% -$2.85M ﹤0.01% 3283
2025
Q1
$6.64M Sell
1,243,476
-122,516
-9% -$654K ﹤0.01% 2733
2024
Q4
$12.2M Buy
1,365,992
+1,305,907
+2,173% +$11.7M ﹤0.01% 2168
2024
Q3
$662K Sell
60,085
-5,589
-9% -$61.5K ﹤0.01% 3896
2024
Q2
$598K Sell
65,674
-60,374
-48% -$549K ﹤0.01% 3805
2024
Q1
$1.77M Buy
126,048
+89,876
+248% +$1.27M ﹤0.01% 3080
2023
Q4
$278K Buy
36,172
+23,245
+180% +$179K ﹤0.01% 4390
2023
Q3
$96.4K Sell
12,927
-1,859
-13% -$13.9K ﹤0.01% 4742
2023
Q2
$123K Buy
14,786
+12,114
+453% +$101K ﹤0.01% 4800
2023
Q1
$35.5K Buy
2,672
+2,668
+66,700% +$35.5K ﹤0.01% 5593
2022
Q4
$60 Sell
4
-3,258
-100% -$48.9K ﹤0.01% 9260
2022
Q3
$29K Buy
3,262
+3,237
+12,948% +$28.8K ﹤0.01% 5823
2022
Q2
$0 Buy
+25
New ﹤0.01% 9232
2022
Q1
Sell
-3,247
Closed -$18K 9141
2021
Q4
$18K Buy
3,247
+239
+8% +$1.33K ﹤0.01% 6842
2021
Q3
$27K Buy
+3,008
New +$27K ﹤0.01% 5720
2021
Q2
Sell
-1,446
Closed -$25K 8248
2021
Q1
$25K Buy
1,446
+174
+14% +$3.01K ﹤0.01% 6147
2020
Q4
$16K Sell
1,272
-4,223
-77% -$53.1K ﹤0.01% 6077
2020
Q3
$204K Sell
5,495
-883
-14% -$32.8K ﹤0.01% 3976
2020
Q2
$246K Buy
+6,378
New +$246K ﹤0.01% 3864
2019
Q3
Sell
-233
Closed -$11K 6987
2019
Q2
$11K Buy
233
+71
+44% +$3.35K ﹤0.01% 6116
2019
Q1
$8K Sell
162
-353
-69% -$17.4K ﹤0.01% 6089
2018
Q4
$14K Buy
+515
New +$14K ﹤0.01% 6105
2018
Q2
Sell
-97
Closed -$11K 7010
2018
Q1
$11K Buy
97
+61
+169% +$6.92K ﹤0.01% 5914
2017
Q4
$3K Sell
36
-13
-27% -$1.08K ﹤0.01% 6540
2017
Q3
$6K Buy
49
+44
+880% +$5.39K ﹤0.01% 6211
2017
Q2
$0 Buy
+5
New ﹤0.01% 6677
2016
Q3
Hold
0
6686
2016
Q2
Hold
0
6767
2015
Q4
Sell
-362
Closed -$176K 6850
2015
Q3
$176K Buy
+362
New +$176K ﹤0.01% 3795